Hadassah and Kadimastem Co-Design Embryonic Stem Cell Protocol for ALS Clinical Trial
Kadimastem, an Israeli biotechnology company, will be conducting a Phase I/IIA clinical trial with its stem cell product, AstroRx®, derived from Hadassah’s clinical grade human embryonic stem cell (hESC) lines….
